Scientists Develop New Technique to Deliver Vaccines without Needles

In this May 5, 2022, file photo, a nurse administers the Pfizer booster shot at a COVID-19 vaccination and testing site in Los Angeles. Frederic J. Brown/AFP via Getty Images, FILE
In this May 5, 2022, file photo, a nurse administers the Pfizer booster shot at a COVID-19 vaccination and testing site in Los Angeles. Frederic J. Brown/AFP via Getty Images, FILE
TT

Scientists Develop New Technique to Deliver Vaccines without Needles

In this May 5, 2022, file photo, a nurse administers the Pfizer booster shot at a COVID-19 vaccination and testing site in Los Angeles. Frederic J. Brown/AFP via Getty Images, FILE
In this May 5, 2022, file photo, a nurse administers the Pfizer booster shot at a COVID-19 vaccination and testing site in Los Angeles. Frederic J. Brown/AFP via Getty Images, FILE

British researchers announced that they have developed a new technique that delivers vaccines in the body without needles. The technique could help deliver vaccines through the skin via ultrasounds without using needles that harm the skin and cause pain. The findings were presented at an international conference in Australia on Monday.

An estimated quarter of adults and two-thirds of children have strong fears around needles, according to the US Centers for Disease Control and Prevention. Yet, public health depends on people being willing to receive vaccines, which are often administered by a jab.

The new method relies on ultrasound pulses to form small bubbles that clear passages through the skin. Then, the pulses deliver the vaccine molecules through the bubbles, which allows its diffusion in the surrounding tissues.

“Our method relies on an acoustic effect called ‘cavitation,’ which is the formation and popping of bubbles in response to a sound wave,” said Darcy Dunn-Lawless, lead author from the University of Oxford’s Institute of Biomedical Engineering.

“We aim to harness the concentrated bursts of mechanical energy produced by these bubble collapses in three main ways. First, to clear passages through the outer layer of dead skin cells and allow vaccine molecules to pass through. Second, to act as a pump that drives the drug molecules into these passages. Lastly, to open up the membranes surrounding the cells themselves, since some types of vaccine must get inside a cell to function,” she explained.

Initial in vivo tests reported that the vaccine molecules delivered by the new approach produced a higher immune response, according to the Eurekalert website.

The researchers theorize this could be due to the immune-rich skin the ultrasonic delivery targets in contrast to the muscles that receive the jab.

According to Lawless, the result is a more efficient vaccine that could help reduce costs and increase efficacy with little risk of side effects. The team plans further research to explore the efficacy and safety of the new approach for specific vaccines like DNA vaccines.



Rwanda and WHO Declare End of Marburg Outbreak after No New Cases Reported

In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
TT

Rwanda and WHO Declare End of Marburg Outbreak after No New Cases Reported

In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)

The World Health Organization and the Rwandan government on Friday declared the outbreak in Rwanda of the Ebola-like Marburg fever over after no new cases were registered in recent weeks.

The country first declared the outbreak on Sept. 27 and reported a total of 15 deaths and 66 cases, with the majority of those affected healthcare workers who handled the first patients.

Without treatment, Marburg can be fatal in up to 88% of people who fall ill with the disease. Symptoms include fever, muscle pains, diarrhea, vomiting and, in some cases, death through extreme blood loss.

There is no authorized vaccine or treatment for Marburg, though Rwanda received hundreds of doses of a vaccine under trial in October.

An outbreak is considered over after 42 days — two 21-day incubation cycles of the virus — elapsed without registering new cases and all existing cases test negative.

Rwanda discharged the last Marburg patient on Nov. 8 and had reported no new confirmed cases since Oct. 30.

However, WHO officials and Rwanda's Health Minister Dr. Sabin Nzanzimana on Friday said risks remain and that people should stay vigilant.

“We believe it’s not completely over because we still face risks, especially from bats. We are continuing to build new strategies, form new health teams, and deploy advanced technologies to track their movements, understand their behavior, and monitor who is interacting with them,” the minister announced during a press conference in the capital, Kigali.

Like Ebola, the Marburg virus is believed to originate in fruit bats and spreads between people through close contact with the bodily fluids of infected individuals or with surfaces, such as contaminated bed sheets.

“I thank the government of Rwanda, its leadership and Rwandans in general for the strong response to achieve this success but the battle continues,” said the WHO representative in Rwanda, Dr. Brain Chirombo.

Marburg outbreaks and individual cases have in the past been recorded in Tanzania, Equatorial Guinea, Angola, Congo, Kenya, South Africa, Uganda and Ghana.

The virus was first identified in 1967 after it caused simultaneous outbreaks of disease in laboratories in the German city of Marburg and in Belgrade in the former Yugoslavia. Seven people died after being exposed to the virus while conducting research on monkeys.